Literature DB >> 12046075

Effect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells.

Geng Tian1, Jie-Ping Yu, He-Sheng Luo, Bao-Ping Yu, Hui Yue, Jian-Ying Li, Qiao Mei.   

Abstract

AIM: Cyclooxygenase-2 (COX-2) has been suggested to be associated with carcinogenesis. We sought to investigate the effect of the selective COX-2 inhibitor, Nimesulide on proliferation and apoptosis of SMMC-7721 human hepatoma cells.
METHODS: This study was carried out on the culture of hepatic carcinoma SMMC-7721 cell line. Various concentrations of Nimesulide (0, 200 micromol/L, 300 micromol/L, 400 micromol/L) were added and incubated. Cell proliferation was detected with MTT colorimetric assay, cell apoptosis by electron microscopy, flow cytometry and TUNEL.
RESULTS: Nimesulide could significantly inhibit SMMC-7721 cells proliferation dose-dependent and in a dependent manner compared with that of the control group. The duration lowest inhibition rate produced by Nimesulide in SMMC-7721 cells was 19.06%, the highest inhibition rate was 58.49%. After incubation with Nimesulide for 72 h, the most highest apoptosis rate and apoptosis index of SMMC-7721 cells comparing with those of the control were 21.20%+/-1.62% vs 2.24%+/-0.26% and 21.23+/-1.78 vs 2.01+/-0.23 (P<0.05).
CONCLUSION: The selective COX-2 inhibitor, Nimesulide can inhibit the proliferation of SMMC-7721 cells and increase apoptosis rate and apoptosis index of SMMC-7721 cells. The apoptosis rate and the apoptosis index are dose-dependent. Under electron microscope SMMC-7721 cells incubated with 300 micromol and 400 micromol Nimesulide show apoptotic characteristics. With the clarification of the mechanism of selective COX-2 inhibitors, These COX-2 selective inhibitors can become the choice of prevention and treatment of cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046075      PMCID: PMC4656426          DOI: 10.3748/wjg.v8.i3.483

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  47 in total

1.  Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells.

Authors:  Z Zhang; R N DuBois
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

2.  Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.

Authors:  V N Shirvani; R Ouatu-Lascar; B S Kaur; M B Omary; G Triadafilopoulos
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

3.  Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3.

Authors:  S N Orlov; N Thorin-Trescases; N O Dulin; T V Dam; M A Fortuno; J Tremblay; P Hamet
Journal:  Cell Death Differ       Date:  1999-07       Impact factor: 15.828

4.  Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide.

Authors:  H Shiotani; A Denda; K Yamamoto; W Kitayama; T Endoh; Y Sasaki; N Tsutsumi; M Sugimura; Y Konishi
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

5.  Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth.

Authors:  M Mann; H Sheng; J Shao; C S Williams; P I Pisacane; M X Sliwkowski; R N DuBois
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

6.  Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor.

Authors:  A Marrogi; H I Pass; M Khan; L J Metheny-Barlow; C C Harris; B I Gerwin
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

7.  Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.

Authors:  M A Molina; M Sitja-Arnau; M G Lemoine; M L Frazier; F A Sinicrope
Journal:  Cancer Res       Date:  1999-09-01       Impact factor: 12.701

Review 8.  The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1996-09       Impact factor: 6.968

9.  Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.

Authors:  V Subbarayan; A L Sabichi; N Llansa; S M Lippman; D G Menter
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

10.  Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.

Authors:  D J Elder; D E Halton; A Hague; C Paraskeva
Journal:  Clin Cancer Res       Date:  1997-10       Impact factor: 12.531

View more
  16 in total

1.  The effects of vitamin E succinate on the expression of c-jun gene and protein in human gastric cancer SGC-7901 cells.

Authors:  Yan Zhao; Kun Wu; Wei Xia; Yu-Juan Shan; Li-Jie Wu; Wei-Ping Yu
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

2.  Preparation, safety, pharmacokinetics, and pharmacodynamics of liposomes containing Brucea javanica oil.

Authors:  Yanxia Cui; Zimei Wu; Xiaoxu Liu; Rui Ni; Xuanxuan Zhu; Lulu Ma; Jianping Liu
Journal:  AAPS PharmSciTech       Date:  2010-05-19       Impact factor: 3.246

3.  Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells.

Authors:  Zhi-Su Liu; Sheng-Li Tang; Zhong-Li Ai
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

4.  Experimental study on ultrasound-guided intratumoral injection of "Star-99" in treatment of hepatocellular carcinoma of nude mice.

Authors:  Li-Wu Lin; Xiao-Dong Lin; Yi-Mi He; Shang-Da Gao; En-Sheng Xue
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.

Authors:  Bo Zhong; Xiaohan Cai; Snigdha Chennamaneni; Xin Yi; Lili Liu; John J Pink; Afshin Dowlati; Yan Xu; Aimin Zhou; Bin Su
Journal:  Eur J Med Chem       Date:  2011-11-15       Impact factor: 6.514

6.  Apoptosis of hepatoma cells SMMC-7721 induced by Ginkgo biloba seed polysaccharide.

Authors:  Qun Chen; Gui-Wen Yang; Li-Guo An
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

7.  Nimesulide inhibits proliferation via induction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line.

Authors:  Jian-Ying Li; Xiao-Zhong Wang; Feng-Lin Chen; Jie-Ping Yu; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

8.  Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma.

Authors:  Ying-Wei Xue; Qi-Fan Zhang; Zhi-Bing Zhu; Qi Wang; Song-Bin Fu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells.

Authors:  Ming-Yi Li; Hua Deng; Jia-Ming Zhao; Dong Dai; Xiao-Yu Tan
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  Serum from rabbit orally administered cobra venom inhibits growth of implanted hepatocellular carcinoma cells in mice.

Authors:  Peng Sun; Xian-Da Ren; Hai-Wei Zhang; Xiao-Hong Li; Shao-Hui Cai; Kai-He Ye; Xiao-Kun Li
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.